MX2009004124A - Nanoparticulas micelares de sustancias quimicas. - Google Patents

Nanoparticulas micelares de sustancias quimicas.

Info

Publication number
MX2009004124A
MX2009004124A MX2009004124A MX2009004124A MX2009004124A MX 2009004124 A MX2009004124 A MX 2009004124A MX 2009004124 A MX2009004124 A MX 2009004124A MX 2009004124 A MX2009004124 A MX 2009004124A MX 2009004124 A MX2009004124 A MX 2009004124A
Authority
MX
Mexico
Prior art keywords
micelles
chemical substances
solid composition
micellar nanoparticles
preparing
Prior art date
Application number
MX2009004124A
Other languages
English (en)
Inventor
Jan P Moeschwitzer
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Priority claimed from PCT/EP2007/061194 external-priority patent/WO2008046905A1/en
Publication of MX2009004124A publication Critical patent/MX2009004124A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a una composición sólida termoestable que contiene micelas nano-dimensionadas, las micelas contienen una sustancia química pobremente soluble, tal como una sustancia biológicamente activa disuelta en un material auxiliar, y las micelas están embebidas en un vehículo soluble en agua; la invención se refiere adicionalmente a un procedimiento para preparar una composición sólida termoestable y a un procedimiento para preparar formas de dosis farmacéuticas que comprenden las mismas.
MX2009004124A 2006-10-20 2007-10-19 Nanoparticulas micelares de sustancias quimicas. MX2009004124A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06122648 2006-10-20
PCT/EP2007/061194 WO2008046905A1 (en) 2006-10-20 2007-10-19 Micellar nanoparticles of chemical substances

Publications (1)

Publication Number Publication Date
MX2009004124A true MX2009004124A (es) 2009-07-22

Family

ID=37671256

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004124A MX2009004124A (es) 2006-10-20 2007-10-19 Nanoparticulas micelares de sustancias quimicas.

Country Status (8)

Country Link
CN (2) CN104188926A (es)
AR (1) AR063330A1 (es)
BR (1) BRPI0719826A8 (es)
HK (1) HK1199829A1 (es)
MX (1) MX2009004124A (es)
SA (1) SA07280548B1 (es)
TW (1) TWI392507B (es)
UA (1) UA97496C2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI661841B (zh) * 2017-04-19 2019-06-11 三凡生技研發股份有限公司 用於分散疏水性植物萃取物之載劑
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
CN110302155B (zh) * 2019-07-31 2021-09-21 江南大学 一种黄原胶共聚物纳米胶束的制备方法及其应用
CN112915121A (zh) * 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 一种大麻素纳米胶束制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
DE60216287T2 (de) * 2001-07-13 2007-05-31 Nanocarrier Co., Ltd. Lyophilisierende zusammensetzung von wirkstoff-verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
WO2005118612A1 (en) * 2004-06-04 2005-12-15 Sonus Pharmaceuticals, Inc. Cholesterol/bile acid/bile acid derivative-modified therapeutic anti-cancer drugs

Also Published As

Publication number Publication date
CN104188926A (zh) 2014-12-10
AR063330A1 (es) 2009-01-21
TW200824711A (en) 2008-06-16
UA97496C2 (ru) 2012-02-27
BRPI0719826A2 (pt) 2014-05-06
CN101686946A (zh) 2010-03-31
BRPI0719826A8 (pt) 2017-04-04
SA07280548B1 (ar) 2011-10-08
HK1199829A1 (en) 2015-07-24
TWI392507B (zh) 2013-04-11

Similar Documents

Publication Publication Date Title
EA200900572A1 (ru) Мицеллярные наночастицы с химическими субстанциями
WO2009130204A3 (en) Improved formulations for poorly permeable active pharmaceutical ingredients
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
MX343314B (es) Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.
WO2007125501A3 (en) Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness
WO2008089151A3 (en) High dose film compositions and methods of preparation
IL190951A0 (en) Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
TW200640502A (en) Tablets with improved drug substance dispersibility
MY161620A (en) Oral care formulations that enhance amount of soluble zinc
GB2452461A (en) Aqueous compositions containing a hydrophobic material
WO2008017867A3 (en) Antiretroviral solid oral composition with at least one water insoluble polymer
WO2011067791A3 (en) Process for preparing pharmaceutical ophthalmic compositions
TW201129392A (en) Dissolvable films containing high concentrations of nonionic surfactants such as polysorbates to enhance high solid loadings
PL2120890T3 (pl) Peletki powlekane
UA92011C2 (ru) Облатка, содержащая стероидные гормоны
GB2443793B (en) Product, method of manufacture and use
MX2009004124A (es) Nanoparticulas micelares de sustancias quimicas.
TW200628468A (en) Bicyclononene derivatives
WO2008039351A3 (en) Method of manufacturing tablets containing pharmacologically active agents
HK1120417A1 (en) Stable nanoparticle formulations
ZA200805598B (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
WO2008079963A3 (en) Pharmaceutical compositions comprising ionic complexes of active pharmaceutical ingredients
PT2007347T (pt) Composiçãocompreendendo um agente para estabilizar substâncias activas na água potável, mistura efervescente, método para a sua produção e seu uso
MXPA05010254A (es) Composicion farmaceutica que contiene complejo de platino como sustancia activa y metodo de fabricacion de la misma.
WO2010149309A3 (de) Cycloalkylamidbenzoxa(thia)zole als fungizide

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration